Log in

NASDAQ:APOPCELLECT BIOTECH/S Stock Price, Forecast & News

$3.13
-0.07 (-2.19 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.13
Now: $3.13
$3.25
50-Day Range
$2.91
MA: $3.12
$3.29
52-Week Range
$0.40
Now: $3.13
$6.89
Volume47,100 shs
Average Volume134,083 shs
Market Capitalization$7.01 million
P/E RatioN/A
Dividend YieldN/A
Beta2.44
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; and Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state. It also has a collaboration with the Washington University School of Medicine to determine the safety and tolerability of ApoGraft for bone marrow transplantations in the United States. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was founded in 2011 and is headquartered in Kfar Saba, Israel.
Read More
CELLECT BIOTECH/S logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APOP
CUSIPN/A
Phone972-9974-1444

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.92 per share

Profitability

Net Income$-4,860,000.00

Miscellaneous

Employees28
Market Cap$7.01 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive APOP News and Ratings via Email

Sign-up to receive the latest news and ratings for APOP and its competitors with MarketBeat's FREE daily newsletter.

CELLECT BIOTECH/S (NASDAQ:APOP) Frequently Asked Questions

How has CELLECT BIOTECH/S's stock been impacted by COVID-19 (Coronavirus)?

CELLECT BIOTECH/S's stock was trading at $1.71 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, APOP stock has increased by 83.0% and is now trading at $3.13. View which stocks have been most impacted by Coronavirus.

When is CELLECT BIOTECH/S's next earnings date?

CELLECT BIOTECH/S is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for CELLECT BIOTECH/S.

How were CELLECT BIOTECH/S's earnings last quarter?

CELLECT BIOTECH/S (NASDAQ:APOP) announced its quarterly earnings data on Thursday, May, 21st. The company reported ($0.22) earnings per share (EPS) for the quarter. View CELLECT BIOTECH/S's earnings history.

Has CELLECT BIOTECH/S been receiving favorable news coverage?

News headlines about APOP stock have been trending very negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CELLECT BIOTECH/S earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about CELLECT BIOTECH/S.

Who are some of CELLECT BIOTECH/S's key competitors?

What other stocks do shareholders of CELLECT BIOTECH/S own?

Who are CELLECT BIOTECH/S's key executives?

CELLECT BIOTECH/S's management team includes the following people:
  • Mr. Kasbian Nuriel Chirich, Co-Founder & Exec. Chairman (Age 61)
  • Dr. Shai Yarkoni, Co-Founder, CEO & Director (Age 61)
  • Mr. Eyal Leibovitz, Chief Financial Officer (Age 58)
  • Dr. Ronit Bakimer-Kleiner, Chief Devel. Officer (Age 57)
  • Dr. Amos Ofer, VP of Operations (Age 43)

What is CELLECT BIOTECH/S's stock symbol?

CELLECT BIOTECH/S trades on the NASDAQ under the ticker symbol "APOP."

How do I buy shares of CELLECT BIOTECH/S?

Shares of APOP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CELLECT BIOTECH/S's stock price today?

One share of APOP stock can currently be purchased for approximately $3.13.

How big of a company is CELLECT BIOTECH/S?

CELLECT BIOTECH/S has a market capitalization of $7.01 million. CELLECT BIOTECH/S employs 28 workers across the globe.

What is CELLECT BIOTECH/S's official website?

The official website for CELLECT BIOTECH/S is www.cellect.co.

How can I contact CELLECT BIOTECH/S?

CELLECT BIOTECH/S's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The company can be reached via phone at 972-9974-1444 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.